Niland, S., Komljenovic, D., Macas, J., Bracht, T., Bäuerle, T., Liebner, S., & Eble, J. A. (2018). Rhodocetin-αβ selectively breaks the endothelial barrier of the tumor vasculature in HT1080 fibrosarcoma and A431 epidermoid carcinoma tumor models. Oncotarget.
Citación estilo ChicagoNiland, Stephan, Dorde Komljenovic, Jadranka Macas, Thilo Bracht, Tobias Bäuerle, Stefan Liebner, y Johannes A. Eble. "Rhodocetin-αβ Selectively Breaks the Endothelial Barrier of the Tumor Vasculature in HT1080 Fibrosarcoma and A431 Epidermoid Carcinoma Tumor Models." Oncotarget 2018.
Cita MLANiland, Stephan, et al. "Rhodocetin-αβ Selectively Breaks the Endothelial Barrier of the Tumor Vasculature in HT1080 Fibrosarcoma and A431 Epidermoid Carcinoma Tumor Models." Oncotarget 2018.